Limitations of current cardiovascular disease risk assessment strategies in women

Journal of Women's Health

Volumn 15, Issue 1, 2006, Pages 54-56

  Sibley, Christopher ^a   Blumenthal, Roger S ^a   Merz, C Noel Bairey ^b   Mosca, Lori ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; ETHNIC DIFFERENCE; EVIDENCE BASED MEDICINE; EXERCISE; FAMILY HISTORY; GOOD CLINICAL PRACTICE; HEALTH EDUCATION; HEART INFARCTION PREVENTION; HIGH RISK POPULATION; HUMAN; LIFESTYLE; MEDICAL DECISION MAKING; METABOLIC DISORDER; NOTE; PATIENT CODING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; PRIMARY PREVENTION; RESEARCH DESIGN; RISK ASSESSMENT; UNITED STATES; WOMEN'S HEALTH;

EID: 32044441439     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.15.54     Document Type: Note

References (13)

1. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004;109:672.
2. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143.
3. Ford ES, Giles WH, Mokdad AH. The distribution of 10-year risk for coronary heart disease among U.S. adults. J Am Coll Cardiol 2004;43:1791.
4. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary disease. Lancet 1999;353:89.
5. Michos ED, Nasir K, Braunstein JB, et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women Atherosclerosis 2005 May 10 [E pub ahead of print].
6. Michos ED, Nasir K, Rumberger JA, et al. Relation of family history of premature coronary heart disease and metabolic risk factors to risk of coronary arterial calcium in asymptomatic subjects. Am J Cardiol 2005;95:655.
7. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population. Am Heart J 1986;111:383.
8. Ridker PM, Cook NR, Lee I-M, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293.
9. Jessup M, Pina I. Is it important to examine gender differences in the epidemiology and outcome of severe heart failure? J Thorac Cardiovasc Surg 2004; 127:1247.
10. Grundy SM, D'Agostino RB, Mosca L, et al. Cardiovascular risk assessment based on U.S. cohort studies: Findings from a National Heart, Lung, and Blood Institute workshop. Circulation 2001;104:491.
11. Gulati M, Black HR, Shaw LJ, et al. The prognostic value of a nomogram for exercise capacity in women. N Eng J Med 2005;353:468.
12. Mora S, Redberg RF, Sharrett AR, Blumenthal RS. Enhanced risk assessment in asymptomatic individuals with exercise testing and Framingham risk scores. Circulation 2005;112:1566.
13. Mieres JH, Shaw LJ, Arai A, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease. Circulation 2005;111: 682.